title: Ceritinib-a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer.
authors: Department Internal Medicine, Medical Oncology, University Hospital Basel, Basel, Switzerland.
authors: Sacha I
authors: SI
authors: Rothschild